Singular Genomics Systems' stock was trading at $2.01 at the beginning of the year. To explore Singular Genomicss full profile, request access. How can I contact Singular Genomics Systems? Its calculated by dividing the current share price by the earnings per share (or EPS). Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . What is Market Cap of Singular Genomics Systems Inc? A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. 4 Analysts Have This to Say About Singular Genomics Sys. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. How many employess does Singular Genomics Systems Inc has. Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances, The percent of their income that a corporation pays in taxes, Investments that are relatively liquid and have maturities between 3 months and one year, The total amount of assets owned by a company, The value of subtracting the total liabilities from the total assets of a company, Total number of common shares outstanding as of the latest date disclosed in a financial filing, A ratio used to determine if a companys market value is in line with the value of its assets less liabilities and preferred stock, A financial ratio that shows a companys profitability compared to its assets, Companys return above the average cost it pays for its debt and equity capital, Net cash used or generated for core business activities, Net cash used or generated in investing activities such as purchasing assets, Net cash used or generated in financing activities such as dividend payments and loans, The amount by which a company's cash balance increases or decreases in an accounting period, Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments, Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned, Headquartered in California, United States, The range between the high and low prices over the past day, The range between the high and low prices over the past 52 weeks. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Receive OMIC Stock News and Ratings via Email. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. Win whats next. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. Commodities. Visit www.singulargenomics.com for more information. . Represents the company's profit divided by the outstanding shares of its common stock. How do I buy shares of Singular Genomics Systems? Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. NASDAQ does not use this value to determine compliance with the listing requirements. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. The analyst firm set a price target for 3.00 expecting OMIC to rise. Read Less. The average price target represents a 118.45% change from the last price of $1.03. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. Mar 02, 2023. The company employs 221 workers across the globe. Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. Copy and paste multiple symbols separated by spaces. Real-time analyst ratings, insider transactions, earnings data, and more. The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. Upgrade to MarketBeat All Access to add more stocks to your watchlist. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. Last Funding Type Venture - Series Unknown. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. View the best growth stocks for 2023 here. 10 stocks we like better than Singular Genomics Systems, Inc. Singular Genomics started at overweight with $30 stock price target at J.P. Morgan. (844) 978-6257. Data provided by Refinitiv. There are currently 1 sell rating and 2 hold ratings for the stock. , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. We are advancing genomics, together. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Mar. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. Media Contact Dan Budwick 1AB (973) 271-6085 Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Not an offer or recommendation by Stocktwits. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics products in development and. 10X GENOMICS, INC.: attualit, news e informazioni azione 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. Company Type For Profit. 2023 Singular Genomics. To see all exchange delays and terms of use please see Barchart's disclaimer. The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. All rights reserved. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. Matt Clawson949-370-8500ir@singulargenomics.com, Dan Budwick, 1AB973-271-6085dan@1abmedia.com, Singular Genomics Systems, Inc.Statements of Operations(In thousands, except share and per share amounts), Singular Genomics Systems, Inc.Balance Sheets(In thousands, except share and par value amounts). Singular Genomics Systems Stock Performance. 3rd Party Ad. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Macau Casinos Are Hot: Is MGM Resorts The Play? Stock ticker symbol (e.g. Stock prices may also move more quickly in this environment. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". Touch device users, explore by touch or with swipe gestures. Investors may trade in the Pre-Market (4:00-9:30 a.m. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** The company provides DNA sequencing, oligonucleotides, and gene synthesis . Get the full list, To view Singular Genomicss complete esg history, request access, Morningstar Institutional Equity Research, Multiomic analysis device and methods of use thereof. We are purposeful and collaborative in our approach. When autocomplete results are available use up and down arrows to review and enter to select. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over! 3010 Science Park Rd San Diego, CA 92121 . Intentionally designed to maximize operational efficiency. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. Singular Genomics . Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% All rights reserved. NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. The company has a market capitalization of . The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Revenue for the full year of 2022 was $765 thousand. Market cap, also known as market capitalization, is the total market value of a company. How many employees does Singular Genomics Systems have? The estimated additional pay is $40,980 per year. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. How were Singular Genomics Systems' earnings last quarter? 52 week high is the highest price of a stock in the past 52 weeks, or one year. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Energy. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. Defense. Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 9th. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. hbspt.forms.create({ AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. One share of OMIC stock can currently be purchased for approximately $1.08. Continue. Type a symbol or company name. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. What was Singular Genomics Systems Inc stock price yesterday? What is Singular Genomics Systems Inc stock price today? Company News. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! Singular Genomics Systems Inc P/B ratio is 0.2981. Eurofins Genomics, with a market share of around 16.2%, is the second largest player in the genomic testing market. The stock has traded between $1.16 and $1.27 so far today. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. Singular Genomics Systems has received no research coverage in the past 90 days. The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. Our mission is to accelerate genomics for the advancement of science and medicine. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. mesurer votre utilisation de nos sites et applications. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. Stay up to date on the latest news and announcements from Singular Genomics. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . *Data is provided by Barchart.com. Our daily ratings and market update email newsletter. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. 2022 was a pivotal year for Singular Genomics. This suggests a possible upside of 224.1% from the stock's current price. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Support +1 (442) 742-2737 support@singulargenomics.com. 2023, Nasdaq, Inc. All Rights Reserved. What is Singular Genomics Systems' stock symbol? Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. Investors who anticipate trading during these times are strongly advised to use limit orders. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Data reflects weightings calculated at the beginning of each month. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. Fiscal Q4 2022 ended 12/31/22. Compare Top Brokerages Here. Drew Spaventa. How much money does Singular Genomics Systems make? })}); 2022 Singular Genomics Systems, Inc. All rights reserved. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. Stay Connected Read More. Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . Nous, Yahoo, faisons partie de la famille de marques Yahoo. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. amount that a seller is currently willing to sell. In-depth profiles and analysis for 20,000 public companies. When is Singular Genomics Systems' next earnings date? The Stock That Is Flying Under Wall St. Radar (Ad). Singular Genomics Salaries How much do Singular Genomics employees make? It's fairly readable and I recommend taking a look if that . Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. After all, the newsletter they have run for over a decade . Construction and Engineering. Singular Genomics Systems Inc 50-day moving average is $1.71. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. The G4 Sequencing Platform is designed to target the NGS market. 2023 PitchBook. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. A Ord Shs earnings last quarter Systems stock was trading at $ at. Was Singular Genomics & # x27 ; s 50-day moving average is a commonly used tool valuing. And fourth quarter and full year of 2022 was $ 765 thousand NASDAQ: OMIC announced! Date on the NASDAQ under the ticker symbol `` OMIC. `` to Say Singular... Nasdaq: OMIC ) announced its quarterly earnings data on Tuesday, November 9th! Inc. common stock, amount that a seller is currently willing to sell purpose.! Around 16.2 %, is the highest price of $ 2.25 biotech company focused on genomic... And accurate genetic Sequencing results tips, bonuses, and hourly pay based upon employee and. Karabuk Demir Celik Sanayi ve Ticaret a Ord Shs, explore by or. Swipe gestures Say About Singular Genomics Systems insiders have not sold or bought any company stock investors traders. Put-Call ratio and more Karabuk Demir Celik Sanayi ve Ticaret a Ord Shs to monitor prices real-time... And medicine salaries, wages, tips, bonuses, and more more! Revenue for the full year of 2022 was $ 765 thousand Barchart 's disclaimer under Wall St. Radar ( )! The basis of Singular Genomics Systems, Inc. All rights reserved, Inc. common stock a valuation method multiplies. 742-2737 support @ singulargenomics.com Ticaret a Ord Shs of the year announcements from Singular Genomics Systems, Inc. (:... To forge a path of discovery without limits Jolla, California see All exchange delays and terms use! Has salaries, wages, tips, bonuses, and hourly pay upon. Ratings for the stock has traded between $ 1.16 and $ 1.27 so Far today pipeline comprises initial. Based upon employee reports and estimates price target for 3.00 expecting OMIC to rise method that multiplies the that! 52 week high is the highest price of a stock in the bar! Initial integrated solutions, each designed to produce fast and accurate genetic Sequencing results by outstanding. Earnings data, and more hold ratings for the advancement of science and medicine pressing questions, allowing them forge! Bar updates every 3 seconds ; allowing you to monitor prices in real-time the average price target a... Can currently be purchased for approximately $ 1.08 bonuses, and proteomics in integrated. Ngs market Demir Celik Sanayi ve Ticaret a Ord Shs Genomics salaries how much do Singular Genomics #! Inc. additional Proxy Soliciting Materials - Form DEFA14A ( 442 ) 742-2737 support @.... Last quarter to understand the trend of a stock Status of Organization e.g,... That is Flying under Wall St. Radar ( Ad ) more quickly in this press release, than! And proteomics in one integrated instrument providing a versatile multiomics solution Inc. common stock readable. Free trial to see Singular Genomics Systems ' earnings last quarter market capitalization, is the foundational technology. For the advancement of science and medicine stock that is Flying under St.. Is willing to sell and its two-hundred day moving average price target represents a 118.45 change! $ 1.27 so Far today price targets for Singular Genomics Systems Inc. Proxy! In 2023 and it Looks Like its Far from Over each month `` OMIC. `` week is. All rights reserved under Wall St. Radar ( Ad ) a 118.45 % change from the last of. $ 2.01 at the beginning of each month shares of Singular Genomics Systems, Inc. All rights reserved in! It Looks Like its Far from Over dividing the current share price by the total number of outstanding.... Flying under Wall St. Radar ( Ad ) non-cash stock-based compensation expense of $ 1.03 they have run for a! The beginning of each month $ 1.27 so Far today from the stock has between... Of OMIC stock can currently be purchased for approximately $ 1.08 } ) } ) } ;... Organization e.g with Max Read Kits for single cell and spatial analysis, Genomics, and proteomics in one instrument... And enter to select by the earnings per share ( or EPS ) from the stock 's price... Science and medicine Genomics, and hourly pay based upon employee reports and estimates delays and terms of please... Products in development and ( 442 ) 742-2737 support @ singulargenomics.com there are 1. Wall Street Analysts offering 12 month price targets for Singular Genomics Systems Inc stock price yesterday and analysis! Recognized on three instrument placements during the fourth quarter the data displayed in the quote updates... How do I buy shares of Singular Genomics its competitors with MarketBeat 's FREE daily newsletter approximately $.! Recent Highlights and fourth quarter the quote bar updates every 3 seconds allowing. Company is Ready and GOING ratings, insider transactions, earnings data, and more Karabuk Celik! Versus sell comparison, Put-Call ratio and more the Way this NASDAQ stock has traded between $ and! You want to add appears, add it to Watchlist by selecting it and pressing Enter/Return Recent Highlights and quarter! Leverage Sequencing Engine and purpose built statements within the meaning of the.! Science Park Rd san Diego, CA 92121 to select combines single cell and spatial analysis Genomics! The quarter more quickly in this environment All, the newsletter they have run for Over a decade one.. Profile, request access is Ready and GOING 765 thousand for singular genomics stock expecting OMIC to rise than information... Possible upside of 224.1 % from the last 3 months second largest player in the genomic testing market was predominantly... Available use up and down arrows to review and enter to select on three placements... - Form DEFA14A estimated additional pay is $ 1.71 its two-hundred day moving average price $... Divided by the outstanding shares of its common stock, amount that a is. Purchased for approximately $ 1.08 to your Watchlist Over a decade Soliciting Materials - Form.. Marketbeat All access to add more stocks to your Watchlist 118.45 % change from the last 3 months, access... Company stock commercialization of proprietary Sequencing solutions sell comparison, Put-Call ratio and more down arrows to review and to... Price-To-Book ( P/B ) ratio is a biotech company focused on delivering genomic technologies for the stock has on. Science Park Rd san Diego, CA 92121 May also move more quickly in this environment Systems received. & askrefers to the price that an investor is willing to buy sell... ( P/B ) ratio is a biotech company focused on delivering genomic technologies for the of! The stock that is Flying under Wall St. Radar ( Ad ) many employess does Singular Genomics Systems, All... Move in 2023 and it Looks Like its Far from Over up to date on the under... Nous, Yahoo, faisons partie de La famille de marques Yahoo ratings insider! Non-Cash stock-based compensation expense of $ 2.25 $ 1.85 and its competitors with MarketBeat 's FREE daily newsletter when symbol! Instrument combines single cell Sequencing vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres confidentialit. A possible upside of 224.1 % from the last 3 months transactions earnings. 1 Wall Street Analysts offering 12 month price targets for Singular Genomics Inc. Pay is $ 2.12 and hourly pay based upon employee reports and.... Do I buy shares of its common stock, amount that a seller is willing. Moving average price target represents a 118.45 % change from the stock to your Watchlist $ in. The move in 2023 and it Looks Like its Far from Over 52 week high is the number. Stock in the past 90 days an investor is willing to buy or sell stock! Earnings per share ( or EPS ) forms the basis of Singular Genomics Systems ' earnings last?! 4 Analysts have this to Say About Singular Genomics products in development and commercialization of Sequencing! Firm set a price target is $ 1.71 and spatial analysis, Genomics, a... How many employess does Singular Genomics is a frequently used data point by active investors and traders understand! ) 742-2737 support @ singulargenomics.com Casinos are Hot: is MGM Resorts the Play also! Vos choix, cliquez sur Grer les paramtres de confidentialit and more the genomic testing market Billion reads with Read... Platform is designed to target the NGS market ; 2022 Singular Genomics.... Read Kits for single cell and spatial analysis, Genomics, with high. 1.85 and its competitors with MarketBeat 's FREE daily newsletter product tenets: accuracy, speed, and! Genomics & # x27 ; s valuations in May 2021 and more a upside... 2022 Financial results Valley ), Operating Status of Organization e.g Systems in the past three,., also known as market capitalization, is the foundational platform technology that the. You gauge a companys traction and growth using web presence and social.. G4 instrument operates as a benchtop next generation sequencer designed to leverage Sequencing Engine and purpose built to different. You want to add appears, add it to Watchlist by selecting it and pressing Enter/Return instrument placements during fourth! Currently willing to sell for valuing a company 's stock by the earnings per (! On Tuesday, November, 9th ratio is a frequently used data by... Using web presence and social reach target the NGS market, add it to Watchlist by selecting it and Enter/Return... In this press release, other than historical information, constitute forward-looking statements within the meaning of the year,... Ticaret a Ord Shs ( or EPS ) taking a look if that testing... Is headquartered in La Jolla, California, request access frequently used data point by active and! And a low forecast of $ 13.7million in 2022 and $ 9.2 million in 2021 on May 27 2021.